Academia
“Our goal is to get information out to the community and to share data as soon as is humanly possible, so that we can help accelerate ongoing efforts in the scientific and medical communities,” said Alex K. Shalek, the Pfizer-Laubach Career Development Associate Professor of Chemistry.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Researchers at Switzerland-based Empa, ETH Zurich and Zurich University Hospital have developed a sensor that has the potential to identify SARS-CoV-2, the novel coronavirus that causes COVID-19, in the air.
According to the research, published in Nature Cell Biology, targeted doses of doxorubicin could potentially inhibit the interaction between two molecular pathways that work together to encourage tumor growth.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
A recent research article from Monash University in Australia showed that in a laboratory setting, the use of ivermectin, a decades-old drug approved to treat head lice infections as well as the treatment of some parasitic worms, inhibited the SARS-CoV-2 within 24 to 48 hours of treatment.
The U.S. Food and Drug Administration granted emergency use authorization to Rutgers’ RUCDR Infinite Biologics for its test that uses saliva.
The Stanford serology test provides results in two to three days and Stanford Health Care can test 500 samples per day. Know what more it has to offer.
A new study shows a cancer therapy drug may reverse the effects of lupus nephritis in patients with systemic lupus erythematosus (SLE, or lupus), an autoimmune disease.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
PRESS RELEASES